Achille Bottiglieri

7PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

|Oct 24, 2022
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy.

Achille Bottiglieri, Pierangela Sepe, Marco Stellato

|Jun 20, 2022
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.

Emma Zattarin, Sara Manglaviti, Giulia Apollonio

|Mar 09, 2022
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.

Caterina Zanella, Alberto Giovanni Leone, Luca Zambelli

|Jan 21, 2022
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.

Arsela Prelaj, Mattia Boeri, Alessandro Robuschi

|May 05, 2021
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.

Francesca Ligorio, Luca Zambelli, Achille Bottiglieri

Pageof 2

Frequent Collaborators

2 joint publications

Stefano Cavalieri

2 joint publications

Daria Maria Filippini

2 joint publications

Emma Zattarin

2 joint publications

Cristiana Bergamini